Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 4648-4656, May 15, 2007. doi: 10.1158/0008-5472.CAN-06-4681
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wijnhoven, S. W.P.
Right arrow Articles by de Vries, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wijnhoven, S. W.P.
Right arrow Articles by de Vries, A.

Molecular Biology, Pathobiology, and Genetics

Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage

Susan W.P. Wijnhoven1, Ewoud N. Speksnijder1, Xiaoling Liu2, Edwin Zwart1, Conny Th. M. vanOostrom1, Rudolf B. Beems1, Esther M. Hoogervorst1, Mirjam M. Schaap1, Laura D. Attardi3, Tyler Jacks4, Harry van Steeg1, Jos Jonkers2 and Annemieke de Vries1

1 Laboratory of Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, Bilthoven, the Netherlands; 2 Division of Molecular Biology, Netherlands Cancer Institute, Amsterdam, the Netherlands; 3 Division of Radiation and Cancer Biology, Department of Radiation Oncology, Department of Genetics, Stanford University School of Medicine, Stanford, California; and 4 Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts

Requests for reprints: Annemieke de Vries, Laboratory of Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, the Netherlands. Phone: 31-30-2743483; Fax: 31-30-2744446; E-mail: Annemieke.de.Vries{at}RIVM.nl.

p53 alterations in human tumors often involve missense mutations that may confer dominant-negative or gain-of-function properties. Dominant-negative effects result in inactivation of wild-type p53 protein in heterozygous mutant cells and as such in a p53 null phenotype. Gain-of-function effects can directly promote tumor development or metastasis through antiapoptotic mechanisms or transcriptional activation of (onco)genes. Here, we show, using conditional mouse technology, that epithelium-specific heterozygous expression of mutant p53 (i.e., the p53.R270H mutation that is equivalent to the human hotspot R273H) results in an increased incidence of spontaneous and UVB-induced skin tumors. Expression of p53.R270H exerted dominant-negative effects on latency, multiplicity, and progression status of UVB-induced but not spontaneous tumors. Surprisingly, gain-of-function properties of p53.R270H were not detected in skin epithelium. Apparently, dominant-negative and gain-of-function effects of mutant p53 are highly tissue specific and become most manifest upon stabilization of p53 after DNA damage. [Cancer Res 2007;67(10):4648–56]




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
M. K. Lee and K. Sabapathy
The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo
J. Cell Sci., June 1, 2008; 121(11): 1899 - 1906.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. B. Martinez-Cruz, M. Santos, M. F. Lara, C. Segrelles, S. Ruiz, M. Moral, C. Lorz, R. Garcia-Escudero, and J. M. Paramio
Spontaneous Squamous Cell Carcinoma Induced by the Somatic Inactivation of Retinoblastoma and Trp53 Tumor Suppressors
Cancer Res., February 1, 2008; 68(3): 683 - 692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.